| Stock | Dividend Yield | P/E Ratio | Dividend Frequency |
Years Paying |
DGR |
|
JNJ Johnson & Johnson
Champions
|
10.01% |
24.29
|
4 |
60 |
6%
|
|
HZNP Horizon Therapeutics Plc
|
- |
49.57
|
- |
- |
-
|
|
CRXTW
|
- |
-
|
- |
- |
-
|
|
OGN Organon & Co.
|
3.30% |
2.59
|
1 |
1 |
-
|
|
CRXT Clarus Therapeutics Holdings Inc
|
- |
-
|
- |
- |
-
|
|
LLY Lilly(Eli) & Co
Challengers
|
5.68% |
34.74
|
4 |
50 |
10%
|
|
MRK Merck & Co Inc
Contenders
|
13.67% |
35.43
|
4 |
60 |
8%
|
|
RHHBY Roche Holding AG
|
0.19% |
21.62
|
1 |
18 |
2%
|
|
GSK Glaxosmithkline plc - ADR
|
22.59% |
14.75
|
3 |
38 |
-1%
|
|
NVS Novartis AG - ADR
|
15.44% |
20.76
|
1 |
25 |
4%
|
|
GWPH GW Pharmaceuticals plc
|
0.70% |
-98.63
|
- |
- |
-
|
|
GRFS Grifols SA - ADR - Level III
|
12.24% |
14.18
|
2 |
9 |
-9%
|
|
BIIB Biogen Inc
|
0.00% |
22.64
|
- |
- |
-
|
|
AZN Astrazeneca plc - ADR
|
9.33% |
41.71
|
2 |
29 |
-12%
|
|
ABBV Abbvie Inc
Challengers
|
18.36% |
29.08
|
4 |
9 |
20%
|
|
BAYRY Bayer Aktiengesellschaft
|
0.23% |
8.61
|
1 |
21 |
0%
|
|
PFE Pfizer Inc.
Contenders
|
14.04% |
18.38
|
4 |
50 |
6%
|
|
GILD Gilead Sciences, Inc.
Challengers
|
15.60% |
17.08
|
4 |
7 |
10%
|
|
BMY Bristol-Myers Squibb Co.
Contenders
|
12.53% |
-26.30
|
4 |
50 |
12%
|
|
AMGN AMGEN Inc.
Contenders
|
12.67% |
21.57
|
4 |
11 |
13%
|
|
SNY Sanofi - ADR
|
15.95% |
8.04
|
2 |
19 |
2%
|